Enzyme Inhibitors
DBCAT000003Pharmacologic class
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. A DrugBank category of 944 drugs. 423 of them are approved.
- Also known as
- Inhibitors, Enzyme
- Drugs
- (Rp)-cAMPS
- 1-deoxymannojirimycin
- 1,10-Phenanthroline
- 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide
- 2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-ureido]-N-methyl-3-phenyl-propionamide
- 2-[3-(5-Mercapto-[1,3,4]thiadiazol-2yl)-ureido]-N-methyl-3-pentafluorophenyl-propionamide
- 2-deoxy-2,3-dehydro-N-acetylneuraminic acid
- 2,4-Dinitrophenol
- 2,5-di-tert-butylhydroquinone
- 3-isobutyl-1-methyl-7H-xanthine
- 3-Methoxybenzamide
- 3,4-Dichloroisocoumarin
- 3,5-Dinitrocatechol
- 4-(2-Aminoethyl)Benzenesulfonyl Fluoride
- 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
- 4-Hydroxyphenylglycine
- 5-(2-methylpiperazine-1-sulfonyl)isoquinoline
- 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine
- 5-Benzylacyclouridine
- 5-iodotubercidin
- 5'-S-methyl-5'-thioadenosine
- 6-O-benzylguanine
- 7-Hydroxystaurosporine
- 7-Nitroindazole
- 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
What you can answer from here — as of August 12, 2022
Which targets do Enzyme Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account